Home / HLTRF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does HLTRF make money? Does HLTRF have pricing power? What's the Earnings Whisper? Will HLTRF profit more as the business scales? What is HLTRF's management track record? Is HLTRF's current price justified?

HLS Therapeutics Inc.

$2.82 -$0.61 (-17.78%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$2.64

Day Range

$2.82 - $2.82

Year Range

$2.64$4.02

Market Cap

88.2M

AVG Volume

486

Trailing/Forward PE

-10.61/-

PEG ratio

0.16

Dividend Yield

Next Earnings Date

2026-11-12

Primary Exchange

Other OTC

Revenue (USD)

HLTRF Revenue (USD) by year
Period	Revenue (USD)
2025	55.73M
2024	56.56M
2023	63.51M
2022	61.47M
2021	60.01M
2020	56.11M
2019	54.16M
2018	61.41M
2017	129.79M
2016	15.8M

Net Income (USD)

HLTRF Net Income (USD) by year
Period	Net Income (USD)
2025	-12.45M
2024	-19.63M
2023	-27.68M
2022	-23.6M
2021	-13.12M
2020	-15.33M
2019	-19.55M
2018	-24.81M
2017	-6.06M
2016	-881.91K

Operating Income (USD)

HLTRF Operating Income (USD) by year
Period	Operating Income (USD)
2025	-4.1M
2024	-7.69M
2023	-10.24M
2022	-13.45M
2021	-6.28M
2020	-12.09M
2019	-4.63M
2018	7.64M
2017	23.33M
2016	-1.27M

EBITDA (USD)

HLTRF EBITDA (USD) by year
Period	EBITDA (USD)
2025	17.44M
2024	17.21M
2023	12.49M
2022	17.76M
2021	25.31M
2020	22.7M
2019	19.33M
2018	50.16M
2017	30.4M
2016	-1.27M

Cash Flows (USD)

HLTRF Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	15.65M
2024	7.45M
2023	15.8M
2022	6.79M
2021	11.92M
2020	-35.33M
2019	23.55M
2018	45.44M
2017	26.99M
2016	-130.62K

EPS (USD)

HLTRF EPS (USD) by year
Period	EPS (USD)
2025	-0.39
2024	-0.61
2023	-0.85
2022	-0.73
2021	-0.41
2020	-0.48
2019	-0.66
2018	-0.92
2017	-0.24
2016	-0.06

Expenses (USD)

HLTRF Expenses (USD) by year
Period	Expenses (USD)
2025	23.42M
2024	26.94M
2023	32.56M
2022	45.73M
2021	36.57M
2020	76.06M
2019	27.21M
2018	19.59M
2017	15.56M
2016	1.39M

Cash & Debt (USD)

HLTRF Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	11.7M
2024	17.46M
2023	21.84M
2022	20.72M
2021	21.18M
2020	20.61M
2019	47.08M
2018	10.93M
2017	36.22M
2016	25.15M

Debt ratios

HLTRF Debt ratios by year
Period	Debt ratios
2025	0.59
2024	0.67
2023	0.83
2022	0.9
2021	0.65
2020	0.71
2019	0.47
2018	1.12

Margins

HLTRF Margins by year
Period	Margins
2025	71.88%
2024	63.34%
2023	76.48%
2022	91.9%
2021	93.38%
2020	93.54%
2019	96.43%
2018	95.77%
2017	92.2%
2016	100.66%

Return on Capital

HLTRF Return on Capital by year
Period	Return on Capital
2025	-20.23%
2024	-27.51%
2023	-28.48%
2022	-18.83%
2021	-8.16%
2020	-9.06%
2019	-10.97%
2018	-15.65%
2017	-3.36%
2016	-3.53%

Shares Outstanding

HLTRF Shares Outstanding by year
Period	Shares Outstanding
2025	31.27M
2024	31.79M
2023	31.98M
2022	32.36M
2021	32.45M
2020	31.56M
2019	30.31M
2018	27.14M
2017	21.05M
2016	25.04M

Dividends (USD)

HLTRF Dividends (USD) by year
Period	Dividends (USD)
2023	0.07
2022	0.15
2021	0.16
2020	0.15
2019	0.15
2018	0.04

Book Value Per Share (USD)

HLTRF Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	1.97
2024	2.24
2023	3.04
2022	3.87
2021	4.95
2020	5.36
2019	5.88
2018	5.84
2017	8.57
2016	1

Total Assets (USD)

HLTRF Total Assets (USD) by year
Period	Total Assets (USD)
2025	137.28M
2024	159.9M
2023	207.99M
2022	241.65M
2021	275.9M
2020	303.91M
2019	319.67M
2018	306.43M
2017	384.65M
2016	25.52M

Free Cash Flow Yield

HLTRF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	20.87%
Sep 26	22.29%
Aug 26	21.32%
Aug 26	21.4%
Aug 26	21.17%
Aug 26	19.75%
Jul 26	19.75%
Jul 26	19.61%
Jul 26	19.04%
Jul 26	19.04%
Jul 26	19.61%
Jun 26	15.83%
Jun 26	15.83%
Jun 26	15.88%
Jun 26	15.88%
May 26	15.35%
May 26	15.35%
May 26	14.63%
May 26	14.63%
May 26	14.54%
Apr 26	14.71%
Apr 26	14.8%
Apr 26	15.59%
Apr 26	16.68%
Mar 26	13.19%
Mar 26	11.78%
Mar 26	11.78%
Mar 26	11.78%
Feb 26	11.78%
Feb 26	11.78%
Feb 26	11.78%
Feb 26	11.78%
Jan 26	11.78%
Jan 26	11.78%
Jan 26	11.78%
Jan 26	11.78%
Jan 26	11.54%
Dec 25	10.78%
Dec 25	10.84%
Dec 25	10.84%
Dec 25	10.69%
Nov 25	10.69%
Nov 25	10.69%
Nov 25	10.69%
Nov 25	9.22%
Oct 25	9.22%
Oct 25	9.22%
Oct 25	9.22%
Oct 25	9.22%
Oct 25	9.76%
Sep 25	8.88%
Sep 25	8.82%
Sep 25	8.82%
Sep 25	8.88%
Aug 25	8.88%
Aug 25	8.88%
Aug 25	9%
Aug 25	9.15%
Aug 25	9.12%
Jul 25	9.46%
Jul 25	9.1%
Jul 25	9.1%
Jul 25	9.22%
Jun 25	6.41%
Jun 25	6.41%
Jun 25	6.41%
Jun 25	6.41%
May 25	7.28%
May 25	7.28%
May 25	7.28%
May 25	7.28%
May 25	6.82%
Apr 25	7.82%
Apr 25	7.92%
Apr 25	7.92%
Apr 25	7.13%
Mar 25	7.81%
Mar 25	7.76%
Mar 25	9.3%
Mar 25	8.73%
Feb 25	8.61%
Feb 25	8.61%
Feb 25	9.3%
Feb 25	9.3%
Jan 25	9%
Jan 25	9%
Jan 25	9.77%
Jan 25	9.23%
Jan 25	9.23%
Dec 24	13.89%
Dec 24	14.77%
Dec 24	15.57%
Dec 24	15.84%
Nov 24	14.38%
Nov 24	15.38%
Nov 24	15.7%
Nov 24	13.69%
Nov 24	14.95%
Oct 24	15.77%
Oct 24	13.16%

Price to Sales

HLTRF Price to Sales by year
Period	Price to Sales
Sep 26	1.58
Sep 26	1.48
Aug 26	1.55
Aug 26	1.54
Aug 26	1.56
Aug 26	1.67
Jul 26	1.67
Jul 26	1.68
Jul 26	1.73
Jul 26	1.73
Jul 26	1.68
Jun 26	1.77
Jun 26	1.77
Jun 26	1.77
Jun 26	1.77
May 26	1.83
May 26	1.83
May 26	1.92
May 26	1.92
May 26	1.93
Apr 26	1.91
Apr 26	1.9
Apr 26	1.8
Apr 26	1.68
Mar 26	1.69
Mar 26	1.89
Mar 26	1.89
Mar 26	1.89
Feb 26	1.89
Feb 26	1.89
Feb 26	1.89
Feb 26	1.89
Jan 26	1.89
Jan 26	1.89
Jan 26	1.89
Jan 26	1.89
Jan 26	1.93
Dec 25	1.93
Dec 25	1.92
Dec 25	1.92
Dec 25	1.95
Nov 25	1.95
Nov 25	1.95
Nov 25	1.95
Nov 25	2.25
Oct 25	2.25
Oct 25	2.25
Oct 25	2.25
Oct 25	2.25
Oct 25	2.13
Sep 25	2.13
Sep 25	2.15
Sep 25	2.15
Sep 25	2.13
Aug 25	2.13
Aug 25	2.13
Aug 25	2.1
Aug 25	2.07
Aug 25	2.07
Jul 25	2
Jul 25	2.08
Jul 25	2.08
Jul 25	2.05
Jun 25	2.06
Jun 25	2.06
Jun 25	2.06
Jun 25	2.06
May 25	1.81
May 25	1.81
May 25	1.81
May 25	1.81
May 25	1.93
Apr 25	1.69
Apr 25	1.66
Apr 25	1.66
Apr 25	1.85
Mar 25	1.8
Mar 25	1.81
Mar 25	1.51
Mar 25	1.61
Feb 25	1.64
Feb 25	1.64
Feb 25	1.51
Feb 25	1.51
Jan 25	1.56
Jan 25	1.56
Jan 25	1.44
Jan 25	1.53
Jan 25	1.53
Dec 24	1.44
Dec 24	1.36
Dec 24	1.29
Dec 24	1.27
Nov 24	1.4
Nov 24	1.31
Nov 24	1.28
Nov 24	1.47
Nov 24	1.34
Oct 24	1.27
Oct 24	1.53

EV/EBITDA

HLTRF EV/EBITDA by year
Period	EV/EBITDA
Sep 26	6.74
Sep 26	6.42
Aug 26	6.63
Aug 26	6.61
Aug 26	6.67
Aug 26	7.02
Jul 26	7.02
Jul 26	7.05
Jul 26	7.21
Jul 26	7.21
Jul 26	7.05
Jun 26	7.85
Jun 26	7.85
Jun 26	7.83
Jun 26	7.83
May 26	8.02
May 26	8.02
May 26	8.31
May 26	8.31
May 26	8.35
Apr 26	8.28
Apr 26	8.24
Apr 26	7.93
Apr 26	7.56
Mar 26	8.36
Mar 26	9.05
Mar 26	9.05
Mar 26	9.05
Feb 26	9.05
Feb 26	9.05
Feb 26	9.05
Feb 26	9.05
Jan 26	9.05
Jan 26	9.05
Jan 26	9.05
Jan 26	9.05
Jan 26	9.18
Dec 25	9.83
Dec 25	9.79
Dec 25	9.79
Dec 25	9.89
Nov 25	9.89
Nov 25	9.89
Nov 25	9.89
Nov 25	11.02
Oct 25	11.02
Oct 25	11.02
Oct 25	11.02
Oct 25	11.02
Oct 25	10.57
Sep 25	9.41
Sep 25	9.46
Sep 25	9.46
Sep 25	9.41
Aug 25	9.41
Aug 25	9.41
Aug 25	9.32
Aug 25	9.21
Aug 25	9.23
Jul 25	9
Jul 25	9.25
Jul 25	9.25
Jul 25	9.16
Jun 25	9.61
Jun 25	9.61
Jun 25	9.61
Jun 25	9.61
May 25	8.8
May 25	8.8
May 25	8.8
May 25	8.8
May 25	9.2
Apr 25	8.39
Apr 25	8.32
Apr 25	8.32
Apr 25	8.93
Mar 25	9.44
Mar 25	9.48
Mar 25	8.43
Mar 25	8.78
Feb 25	8.86
Feb 25	8.86
Feb 25	8.43
Feb 25	8.43
Jan 25	8.61
Jan 25	8.61
Jan 25	8.18
Jan 25	8.47
Jan 25	8.47
Dec 24	8.32
Dec 24	8.01
Dec 24	7.76
Dec 24	7.68
Nov 24	8.15
Nov 24	7.82
Nov 24	7.72
Nov 24	8.4
Nov 24	7.95
Oct 24	7.7
Oct 24	8.62

Price/Operating Cashflow

HLTRF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	4.45
Sep 26	4.17
Aug 26	4.36
Aug 26	4.34
Aug 26	4.39
Aug 26	4.71
Jul 26	4.71
Jul 26	4.74
Jul 26	4.88
Jul 26	4.88
Jul 26	4.74
Jun 26	5.79
Jun 26	5.79
Jun 26	5.77
Jun 26	5.77
May 26	5.97
May 26	5.97
May 26	6.27
May 26	6.27
May 26	6.3
Apr 26	6.23
Apr 26	6.19
Apr 26	5.88
Apr 26	5.5
Mar 26	6.81
Mar 26	7.63
Mar 26	7.63
Mar 26	7.63
Feb 26	7.63
Feb 26	7.63
Feb 26	7.63
Feb 26	7.63
Jan 26	7.63
Jan 26	7.63
Jan 26	7.63
Jan 26	7.63
Jan 26	7.79
Dec 25	8.47
Dec 25	8.42
Dec 25	8.42
Dec 25	8.54
Nov 25	8.54
Nov 25	8.54
Nov 25	8.54
Nov 25	9.9
Oct 25	9.9
Oct 25	9.9
Oct 25	9.9
Oct 25	9.9
Oct 25	9.35
Sep 25	11.22
Sep 25	11.31
Sep 25	11.31
Sep 25	11.22
Aug 25	11.22
Aug 25	11.22
Aug 25	11.07
Aug 25	10.89
Aug 25	10.92
Jul 25	10.54
Jul 25	10.95
Jul 25	10.95
Jul 25	10.81
Jun 25	15.58
Jun 25	15.58
Jun 25	15.58
Jun 25	15.58
May 25	13.71
May 25	13.71
May 25	13.71
May 25	13.71
May 25	14.64
Apr 25	12.77
Apr 25	12.6
Apr 25	12.6
Apr 25	14
Mar 25	12.77
Mar 25	12.85
Mar 25	10.73
Mar 25	11.44
Feb 25	11.59
Feb 25	11.59
Feb 25	10.73
Feb 25	10.73
Jan 25	11.08
Jan 25	11.08
Jan 25	10.22
Jan 25	10.81
Jan 25	10.81
Dec 24	7.16
Dec 24	6.74
Dec 24	6.39
Dec 24	6.28
Nov 24	6.92
Nov 24	6.47
Nov 24	6.34
Nov 24	7.27
Nov 24	6.66
Oct 24	6.31
Oct 24	7.56

Price to Book

HLTRF Price to Book by year
Period	Price to Book
Sep 26	1.5
Sep 26	1.41
Aug 26	1.47
Aug 26	1.46
Aug 26	1.48
Aug 26	1.59
Jul 26	1.59
Jul 26	1.6
Jul 26	1.64
Jul 26	1.64
Jul 26	1.6
Jun 26	1.61
Jun 26	1.61
Jun 26	1.6
Jun 26	1.6
May 26	1.66
May 26	1.66
May 26	1.74
May 26	1.74
May 26	1.75
Apr 26	1.73
Apr 26	1.72
Apr 26	1.63
Apr 26	1.52
Mar 26	1.53
Mar 26	1.71
Mar 26	1.71
Mar 26	1.71
Feb 26	1.71
Feb 26	1.71
Feb 26	1.71
Feb 26	1.71
Jan 26	1.71
Jan 26	1.71
Jan 26	1.71
Jan 26	1.71
Jan 26	1.74
Dec 25	1.64
Dec 25	1.63
Dec 25	1.63
Dec 25	1.65
Nov 25	1.65
Nov 25	1.65
Nov 25	1.65
Nov 25	1.91
Oct 25	1.91
Oct 25	1.91
Oct 25	1.91
Oct 25	1.91
Oct 25	1.81
Sep 25	1.81
Sep 25	1.82
Sep 25	1.82
Sep 25	1.81
Aug 25	1.81
Aug 25	1.81
Aug 25	1.78
Aug 25	1.76
Aug 25	1.76
Jul 25	1.7
Jul 25	1.77
Jul 25	1.77
Jul 25	1.74
Jun 25	1.63
Jun 25	1.63
Jun 25	1.63
Jun 25	1.63
May 25	1.43
May 25	1.43
May 25	1.43
May 25	1.43
May 25	1.53
Apr 25	1.34
Apr 25	1.32
Apr 25	1.32
Apr 25	1.47
Mar 25	1.3
Mar 25	1.31
Mar 25	1.09
Mar 25	1.17
Feb 25	1.18
Feb 25	1.18
Feb 25	1.09
Feb 25	1.09
Jan 25	1.13
Jan 25	1.13
Jan 25	1.04
Jan 25	1.1
Jan 25	1.1
Dec 24	1.04
Dec 24	0.97
Dec 24	0.92
Dec 24	0.91
Nov 24	1
Nov 24	0.94
Nov 24	0.92
Nov 24	1.05
Nov 24	0.96
Oct 24	0.91
Oct 24	1.09

No video analysis for this stock yet. Request one from our team.

News: HLTRF

marketbeat.com · 12 Aug 2026

HLS Therapeutics Q2 Earnings Call Highlights

HLS Therapeutics TSE: HLS reported second-quarter fiscal 2026 revenue growth as its cardiovascular portfolio expanded 25% year over year, led by continued gains for Vascepa and the first full quarter of sales for newly launched NILEMDO.

AI Analysis

HLS Therapeutics Inc.

Video analysis: HLTRF

News: HLTRF

HLS Therapeutics Q2 Earnings Call Highlights

Similar companies